Louis M Weiner Selected Research

Phosphotransferases (Kinase)

12/2015	Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.
12/2014	c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis M Weiner Research Topics

Disease

85	Neoplasms (Cancer) 02/2024 - 01/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 04/2003
11	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2003
10	Adenocarcinoma 02/2024 - 04/2003
6	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2005
4	Fatigue 05/2015 - 10/2002
4	Carcinoma (Carcinomatosis) 05/2013 - 10/2003
3	Pathologic Complete Response 02/2024 - 02/2006
3	Fibrosis (Cirrhosis) 01/2020 - 08/2008
3	Neoplasm Metastasis (Metastasis) 12/2016 - 01/2006
3	Diarrhea 02/2008 - 10/2002
3	Neutropenia 06/2004 - 10/2002
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2012 - 01/2003
2	Lymphoma (Lymphomas) 12/2012 - 05/2008
2	Carcinogenesis 04/2010 - 01/2006
2	Circulating Neoplastic Cells 04/2008 - 07/2006
2	Vomiting 02/2008 - 04/2003
2	Exanthema (Rash) 11/2005 - 04/2003
1	Melanoma (Melanoma, Malignant) 11/2021
1	Pancreatitis 01/2021
1	Injection Site Reaction 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Arthritis (Polyarthritis) 01/2020

Drug/Important Bio-Agent (IBA)

21	Monoclonal AntibodiesIBA 12/2023 - 01/2003
14	AntibodiesIBA 01/2018 - 08/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
6	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 10/2003
6	ErbB Receptors (EGF Receptor)IBA 12/2015 - 11/2005
6	AntigensIBA 11/2014 - 09/2004
5	Trastuzumab (Herceptin)FDA Link 01/2018 - 09/2005
5	Biomarkers (Surrogate Marker)IBA 04/2016 - 04/2008
4	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2018
4	Surface Antigens (Surface Antigen)IBA 06/2018 - 01/2003
4	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2010
4	Immunoconjugates (Immunoconjugate)IBA 01/2015 - 01/2003
3	CytokinesIBA 11/2021 - 12/2012
3	RNA (Ribonucleic Acid)IBA 11/2021 - 06/2005
3	Gemcitabine FDA Link 01/2021 - 02/2011
3	VaccinesIBA 01/2021 - 06/2004
3	Messenger RNA (mRNA)IBA 01/2021 - 09/2011
3	Serine Proteases (Serine Protease)IBA 01/2020 - 08/2002
3	MicroRNAs (MicroRNA)IBA 03/2016 - 09/2011
3	Capecitabine (Xeloda)FDA Link 03/2016 - 02/2008
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2015 - 12/2004
3	Bispecific AntibodiesIBA 01/2015 - 12/2004
3	Radioisotopes (Radionuclides)IBA 11/2014 - 01/2003
2	ChemokinesIBA 01/2024 - 12/2012
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 11/2021 - 03/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 02/2008
2	veliparibIBA 10/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 03/2004
2	Lapatinib (GW572016)FDA Link 03/2016 - 12/2015
2	Phosphotransferases (Kinase)IBA 12/2015 - 12/2014
2	Tyrosine (L-Tyrosine)FDA Link 12/2015 - 03/2004
2	Growth Factor ReceptorsIBA 12/2015 - 01/2003
2	Docetaxel (Taxotere)FDA Link 05/2015 - 02/2011
2	Bortezomib (Velcade)FDA Link 06/2014 - 02/2008
2	Proteasome InhibitorsIBA 06/2014 - 02/2008
2	Epithelial Cell Adhesion MoleculeIBA 05/2013 - 07/2006
2	Single-Chain AntibodiesIBA 05/2013 - 03/2006
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 09/2011
2	Indicators and Reagents (Reagents)IBA 12/2012 - 03/2009
2	EpitopesIBA 03/2011 - 09/2009
2	Bevacizumab (Avastin)FDA Link 02/2011 - 09/2005
2	Cancer VaccinesIBA 04/2010 - 09/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2008 - 04/2003
2	Cisplatin (Platino)FDA LinkGeneric 02/2006 - 10/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2006 - 10/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2004 - 10/2002
2	tipifarnib (R115777)IBA 06/2004 - 04/2003
2	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2004 - 04/2003
1	Protons (Proton)IBA 09/2023
1	Chimeric Antigen ReceptorsIBA 10/2022
1	Small Cytoplasmic RNAIBA 11/2021
1	InflammasomesIBA 11/2021
1	IpilimumabIBA 11/2021
1	osteoblast cadherinIBA 01/2021
1	ruxolitinibIBA 01/2021
1	Janus KinasesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	artemisinin (artemisinine)IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	B7-H1 AntigenIBA 01/2018
1	ArtesunateIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2018

Therapy/Procedure

55	Therapeutics 12/2023 - 01/2003
17	Immunotherapy 01/2024 - 06/2008
12	Drug Therapy (Chemotherapy) 02/2024 - 01/2003
5	Radiotherapy 02/2024 - 03/2004
2	Adjuvant Chemotherapy 01/2013 - 09/2005
2	Chemoradiotherapy 10/2007 - 02/2006
1	Neoadjuvant Therapy 02/2024
1	Proton Therapy 09/2023
1	Injections 01/2021